Skip to main content
Premium Trial:

Request an Annual Quote

Not Quite the Salmon of Doubt

When there's an industry built up around doubting solid scientific results, the blogger at Adaptive Complexity wonders how people, even scientists looking outside their scope of expertise, can know the difference between a real and settled scientific debate, particularly when it is a complicated subject. "But there is hope: good scientists who speak to the public should be frank about the shortcomings and possible alternate interpretations of their work, but when they are confident about a result, they should say so forcefully and explain why alternate ideas have failed on the evidence," says the post.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.